{"id":"https://openalex.org/W2092580324","doi":"https://doi.org/10.1021/bc034103t","title":"Multivalent Poly(ethylene glycol)-Containing Conjugates for In Vivo Antibody Suppression","display_name":"Multivalent Poly(ethylene glycol)-Containing Conjugates for In Vivo Antibody Suppression","publication_year":2003,"publication_date":"2003-10-28","ids":{"openalex":"https://openalex.org/W2092580324","doi":"https://doi.org/10.1021/bc034103t","mag":"2092580324","pmid":"https://pubmed.ncbi.nlm.nih.gov/14624619"},"language":"en","primary_location":{"id":"doi:10.1021/bc034103t","doi":"https://doi.org/10.1021/bc034103t","is_oa":false,"landing_page_url":"https://doi.org/10.1021/bc034103t","pdf_url":null,"source":{"id":"https://openalex.org/S155115410","display_name":"Bioconjugate Chemistry","issn_l":"1043-1802","issn":["1043-1802","1520-4812"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Bioconjugate Chemistry","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5023386562","display_name":"David S. Jones","orcid":"https://orcid.org/0000-0002-2936-4890","observed_orcids":["https://orcid.org/0000-0002-2936-4890"]},"institutions":[{"id":"https://openalex.org/I4210147868","display_name":"La Jolla Pharmaceutical (United States)","ror":"https://ror.org/04wbpm451","country_code":"US","type":"company","lineage":["https://openalex.org/I4210147868"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"David S. Jones","raw_affiliation_strings":["La Jolla Pharmaceutical Company, 6455 Nancy Ridge Drive, San Diego, California 92121","La Jolla Pharmaceutical Company, 6455 Nancy Ridge Drive, San Diego, California 92121, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"La Jolla Pharmaceutical Company, 6455 Nancy Ridge Drive, San Diego, California 92121","institution_ids":["https://openalex.org/I4210147868"]},{"raw_affiliation_string":"La Jolla Pharmaceutical Company, 6455 Nancy Ridge Drive, San Diego, California 92121, USA","institution_ids":["https://openalex.org/I4210147868"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051844405","display_name":"Michael J. Branks","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210147868","display_name":"La Jolla Pharmaceutical (United States)","ror":"https://ror.org/04wbpm451","country_code":"US","type":"company","lineage":["https://openalex.org/I4210147868"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael J. Branks","raw_affiliation_strings":["La Jolla Pharmaceutical Company, 6455 Nancy Ridge Drive, San Diego, California 92121"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"La Jolla Pharmaceutical Company, 6455 Nancy Ridge Drive, San Diego, California 92121","institution_ids":["https://openalex.org/I4210147868"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053882032","display_name":"Mary-Ann Campbell","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210147868","display_name":"La Jolla Pharmaceutical (United States)","ror":"https://ror.org/04wbpm451","country_code":"US","type":"company","lineage":["https://openalex.org/I4210147868"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mary-Ann Campbell","raw_affiliation_strings":["La Jolla Pharmaceutical Company, 6455 Nancy Ridge Drive, San Diego, California 92121"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"La Jolla Pharmaceutical Company, 6455 Nancy Ridge Drive, San Diego, California 92121","institution_ids":["https://openalex.org/I4210147868"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011148367","display_name":"Keith A. Cockerill","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210147868","display_name":"La Jolla Pharmaceutical (United States)","ror":"https://ror.org/04wbpm451","country_code":"US","type":"company","lineage":["https://openalex.org/I4210147868"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Keith A. Cockerill","raw_affiliation_strings":["La Jolla Pharmaceutical Company, 6455 Nancy Ridge Drive, San Diego, California 92121"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"La Jolla Pharmaceutical Company, 6455 Nancy Ridge Drive, San Diego, California 92121","institution_ids":["https://openalex.org/I4210147868"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016477311","display_name":"Jeffrey R. Hammaker","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210147868","display_name":"La Jolla Pharmaceutical (United States)","ror":"https://ror.org/04wbpm451","country_code":"US","type":"company","lineage":["https://openalex.org/I4210147868"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jeffrey R. Hammaker","raw_affiliation_strings":["La Jolla Pharmaceutical Company, 6455 Nancy Ridge Drive, San Diego, California 92121"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"La Jolla Pharmaceutical Company, 6455 Nancy Ridge Drive, San Diego, California 92121","institution_ids":["https://openalex.org/I4210147868"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026997283","display_name":"Christina A. Kessler","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210147868","display_name":"La Jolla Pharmaceutical (United States)","ror":"https://ror.org/04wbpm451","country_code":"US","type":"company","lineage":["https://openalex.org/I4210147868"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Christina A. Kessler","raw_affiliation_strings":["La Jolla Pharmaceutical Company, 6455 Nancy Ridge Drive, San Diego, California 92121"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"La Jolla Pharmaceutical Company, 6455 Nancy Ridge Drive, San Diego, California 92121","institution_ids":["https://openalex.org/I4210147868"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Eric M. Smith","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210147868","display_name":"La Jolla Pharmaceutical (United States)","ror":"https://ror.org/04wbpm451","country_code":"US","type":"company","lineage":["https://openalex.org/I4210147868"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Eric M. Smith","raw_affiliation_strings":["La Jolla Pharmaceutical Company, 6455 Nancy Ridge Drive, San Diego, California 92121"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"La Jolla Pharmaceutical Company, 6455 Nancy Ridge Drive, San Diego, California 92121","institution_ids":["https://openalex.org/I4210147868"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Anping Tao","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210147868","display_name":"La Jolla Pharmaceutical (United States)","ror":"https://ror.org/04wbpm451","country_code":"US","type":"company","lineage":["https://openalex.org/I4210147868"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Anping Tao","raw_affiliation_strings":["La Jolla Pharmaceutical Company, 6455 Nancy Ridge Drive, San Diego, California 92121"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"La Jolla Pharmaceutical Company, 6455 Nancy Ridge Drive, San Diego, California 92121","institution_ids":["https://openalex.org/I4210147868"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111757322","display_name":"Huong\u2010Thu Ton\u2010Nu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210147868","display_name":"La Jolla Pharmaceutical (United States)","ror":"https://ror.org/04wbpm451","country_code":"US","type":"company","lineage":["https://openalex.org/I4210147868"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Huong-Thu Ton-Nu","raw_affiliation_strings":["La Jolla Pharmaceutical Company, 6455 Nancy Ridge Drive, San Diego, California 92121"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"La Jolla Pharmaceutical Company, 6455 Nancy Ridge Drive, San Diego, California 92121","institution_ids":["https://openalex.org/I4210147868"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5101535127","display_name":"Tong Xu","orcid":"https://orcid.org/0009-0008-8774-6986","observed_orcids":["https://orcid.org/0009-0008-8774-6986"]},"institutions":[{"id":"https://openalex.org/I4210147868","display_name":"La Jolla Pharmaceutical (United States)","ror":"https://ror.org/04wbpm451","country_code":"US","type":"company","lineage":["https://openalex.org/I4210147868"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Tong Xu","raw_affiliation_strings":["La Jolla Pharmaceutical Company, 6455 Nancy Ridge Drive, San Diego, California 92121"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"La Jolla Pharmaceutical Company, 6455 Nancy Ridge Drive, San Diego, California 92121","institution_ids":["https://openalex.org/I4210147868"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5023386562"],"corresponding_institution_ids":["https://openalex.org/I4210147868"],"apc_list":{"value":4500,"currency":"USD","value_usd":4500},"apc_paid":null,"fwci":0.5235,"has_fulltext":false,"cited_by_count":12,"citation_normalized_percentile":{"value":0.65416846,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":95},"biblio":{"volume":"14","issue":"6","first_page":"1067","last_page":"1076"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10308","display_name":"Systemic Lupus Erythematosus Research","score":0.9688000082969666,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10308","display_name":"Systemic Lupus Erythematosus Research","score":0.9688000082969666,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.008500000461935997,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10405","display_name":"Advanced Polymer Synthesis and Characterization","score":0.003599999938160181,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/polyethylene-glycol","display_name":"polyethylene glycol","score":0.9390000104904175},{"id":"https://openalex.org/keywords/antiphospholipid-syndrome","display_name":"antiphospholipid syndrome","score":0.8100000023841858},{"id":"https://openalex.org/keywords/tolerogens","display_name":"tolerogens","score":0.6899999976158142},{"id":"https://openalex.org/keywords/plasma-half-life","display_name":"plasma half-life","score":0.8429999947547913},{"id":"https://openalex.org/keywords/oxime-linkage","display_name":"oxime linkage","score":0.8930000066757202}],"concepts":[{"id":"https://openalex.org/C197336794","wikidata":"https://www.wikidata.org/wiki/Q5161150","display_name":"Conjugate","level":2,"score":0.9174522161483765},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.9122840166091919},{"id":"https://openalex.org/C2777516009","wikidata":"https://www.wikidata.org/wiki/Q194207","display_name":"Ethylene glycol","level":2,"score":0.8387194871902466},{"id":"https://openalex.org/C54400483","wikidata":"https://www.wikidata.org/wiki/Q1793202","display_name":"PEG ratio","level":2,"score":0.8035552501678467},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.7321946620941162},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.6232221126556396},{"id":"https://openalex.org/C124815738","wikidata":"https://www.wikidata.org/wiki/Q41509","display_name":"Mole","level":2,"score":0.4423118531703949},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.3060680627822876},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.14178591966629028},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.1306595802307129},{"id":"https://openalex.org/C162324750","wikidata":"https://www.wikidata.org/wiki/Q8134","display_name":"Economics","level":0,"score":0.0},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0},{"id":"https://openalex.org/C134306372","wikidata":"https://www.wikidata.org/wiki/Q7754","display_name":"Mathematical analysis","level":1,"score":0.0},{"id":"https://openalex.org/C33923547","wikidata":"https://www.wikidata.org/wiki/Q395","display_name":"Mathematics","level":0,"score":0.0},{"id":"https://openalex.org/C10138342","wikidata":"https://www.wikidata.org/wiki/Q43015","display_name":"Finance","level":1,"score":0.0},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000917","descriptor_name":"Antibody Formation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001323","descriptor_name":"Autoantibodies","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006023","descriptor_name":"Glycoproteins","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D006023","descriptor_name":"Glycoproteins","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D006023","descriptor_name":"Glycoproteins","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D007108","descriptor_name":"Immune Tolerance","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007165","descriptor_name":"Immunosuppression Therapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D007205","descriptor_name":"Indium Radioisotopes","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008815","descriptor_name":"Mice, Inbred Strains","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008970","descriptor_name":"Molecular Weight","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011092","descriptor_name":"Polyethylene Glycols","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D011092","descriptor_name":"Polyethylene Glycols","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D011092","descriptor_name":"Polyethylene Glycols","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D015394","descriptor_name":"Molecular Structure","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017207","descriptor_name":"Rats, Sprague-Dawley","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018796","descriptor_name":"Immunoconjugates","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D018796","descriptor_name":"Immunoconjugates","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D018796","descriptor_name":"Immunoconjugates","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D053482","descriptor_name":"beta 2-Glycoprotein I","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1021/bc034103t","doi":"https://doi.org/10.1021/bc034103t","is_oa":false,"landing_page_url":"https://doi.org/10.1021/bc034103t","pdf_url":null,"source":{"id":"https://openalex.org/S155115410","display_name":"Bioconjugate Chemistry","issn_l":"1043-1802","issn":["1043-1802","1520-4812"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Bioconjugate Chemistry","raw_type":"journal-article"},{"id":"pmid:14624619","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/14624619","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Bioconjugate chemistry","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9391000270843506,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307775","display_name":"La Jolla Pharmaceutical Company","ror":"https://ror.org/04wbpm451"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":5,"referenced_works":["https://openalex.org/W298125099","https://openalex.org/W1577603732","https://openalex.org/W2025660357","https://openalex.org/W2082850131","https://openalex.org/W2140646145"],"related_works":["https://openalex.org/W2025660357","https://openalex.org/W2944867446","https://openalex.org/W1974103454","https://openalex.org/W4403845274","https://openalex.org/W2995410290","https://openalex.org/W2557421336","https://openalex.org/W1645869234","https://openalex.org/W2567586699","https://openalex.org/W2051745154","https://openalex.org/W2083112584"],"abstract_inverted_index":{"Poly(ethylene":[0],"glycol)":[1],"(PEG)":[2],"was":[3,17,126,176],"incorporated":[4,18,74],"into":[5,63],"multivalent":[6,56],"conjugates":[7,27,100,137,167,184],"of":[8,12,23,25,41,47,55,72,120,135,164,180,195,201],"the":[9,21,26,39,45,64,108,136,183,187,193,199],"N-terminal":[10],"domain":[11,114],"beta(2)GPI":[13],"(domain":[14],"1).":[15],"PEG":[16,62,73,181,202],"to":[19,31,82,144,156,168],"reduce":[20],"rate":[22],"elimination":[24],"from":[28,76,139,151],"plasma":[29,118],"and":[30,44,111,131,150,192],"putatively":[32],"improve":[33],"their":[34],"efficacy":[35],"as":[36],"toleragens":[37],"for":[38,190],"suppression":[40],"anti-beta(2)GPI":[42],"antibodies":[43,172],"treatment":[46],"antiphospholipid":[48],"syndrome":[49],"(APS).":[50],"Three":[51],"structurally":[52],"distinct":[53],"types":[54],"platforms":[57,89],"were":[58,90,101],"constructed":[59],"by":[60,103],"incorporating":[61],"platform":[65],"structures":[66],"in":[67,128,148,160,173,182],"different":[68],"ways.":[69],"The":[70,88,99,117,133,162],"amount":[71,194,200],"ranged":[75,138],"about":[77,83,145,157],"5000":[78],"g":[79,85],"per":[80,86],"mole":[81],"30000":[84],"mole.":[87],"functionalized":[91],"with":[92,124,198],"either":[93],"four":[94],"or":[95],"eight":[96],"aminooxy":[97,109],"groups.":[98],"prepared":[102],"forming":[104],"oxime":[105],"linkages":[106],"between":[107],"groups":[110],"N-terminally":[112],"glyoxylated":[113],"1":[115,146,171],"polypeptide.":[116],"half-life":[119],"each":[121],"conjugate,":[122],"labeled":[123],"(125)I,":[125],"measured":[127],"both":[129],"mice":[130],"rats.":[132,161],"half-lives":[134],"less":[140,152],"than":[141,153],"10":[142],"min":[143],"h":[147,155,159],"mice,":[149],"3":[154],"19":[158],"ability":[163],"five":[165],"tetravalent":[166],"suppress":[169],"anti-domain":[170],"immunized":[174],"rats":[175],"also":[177],"measured.":[178],"Incorporation":[179],"significantly":[185],"reduced":[186],"doses":[188],"required":[189],"suppression,":[191],"reduction":[196],"correlated":[197],"incorporated.":[203]},"counts_by_year":[{"year":2022,"cited_by_count":2},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}